Stoa‐Birketvedt 1998
Study design: RCT
Follow‐up interval: 12 weeks
C, control group
I, intervention group
SE, standard error
RCT, randomized controlled trial
SBP, systolic blood pressure
DBP, diastolic blood pressure |
1. Weight change (kg)
Delta I (SE): ‐5 (0.5)
Delta C (SE): ‐1.3 (0.2)
Delta (I‐C) (SE): ‐3.7 (2.0)
2. BMI (kg/m2)
Delta I (SE): ‐1.6 (0.5)
Delta C (SE): ‐0.4 (0.6)
Delta (I‐C) (SE): ‐1.2 (0.8)
3. % of weight loss
Delta I (SE): ‐4.8 (0.5)
Delta C (SE): ‐1.3 (0.2)
Delta (I‐C) (SE): ‐3.5 (0.5) |
1. GHb (%)
Delta I (SE): ‐0.5 (0.2)
Delta C (SE): ‐0.3 (0.2)
Delta (I‐C) (SE): ‐0.2 (0.3)
2. Fasting blood sugar (mml/L)
Delta I (SE): ‐1.3 (0.4)
Delta C (SE): ‐0.5 (0.4)
Delta (I‐C) (SE): ‐0.8 (0.5) |
1. Total cholesterol (mmol/L)
Delta I (SE): ‐0.1 (0.2)
Delta C (SE): ‐0.3 (0.2)
Delta (I‐C) (SE): 0.2 (0.2)
2. HDL cholesterol (mmol/L)
Delta I (SE): 0.1 (0.0)
Delta C (SE): ‐0.1 (0.0)
Delta (I‐C) (SE): 0.2 (0.1)
3. Triglycerides (mmol/L)
Delta I (SE): ‐0.5 (0.2)
Delta C (SE): 0 (0.4)
Delta (I‐C) (SE): ‐0.5 (0.4) |
1. SBP
Delta I (SE): ‐6.9 (2.6)
Delta C (SE): ‐7.0 (2.7)
Delta (I‐C) (SE): 0.1 (2.7)
2. DBP
Delta I (SE): ‐6.0 (1.5)
Delta C (SE): ‐3.0 (1.0)
Delta (I‐C) (SE): ‐3.0 (1.0) |